BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 22230366)

  • 1. Thioredoxin-1 and protein disulfide isomerase catalyze the reduction of similar disulfides in HIV gp120.
    Reiser K; François KO; Schols D; Bergman T; Jörnvall H; Balzarini J; Karlsson A; Lundberg M
    Int J Biochem Cell Biol; 2012 Mar; 44(3):556-62. PubMed ID: 22230366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human glutaredoxin-1 catalyzes the reduction of HIV-1 gp120 and CD4 disulfides and its inhibition reduces HIV-1 replication.
    Auwerx J; Isacsson O; Söderlund J; Balzarini J; Johansson M; Lundberg M
    Int J Biochem Cell Biol; 2009 Jun; 41(6):1269-75. PubMed ID: 19038358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progress in targeting HIV-1 entry.
    Ryser HJ; Flückiger R
    Drug Discov Today; 2005 Aug; 10(16):1085-94. PubMed ID: 16182193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Cellular Thioredoxin-1/Thioredoxin Reductase-1 Driven Oxidoreduction Represents a Chemotherapeutic Target for HIV-1 Entry Inhibition.
    Reiser K; Mathys L; Curbo S; Pannecouque C; Noppen S; Liekens S; Engman L; Lundberg M; Balzarini J; Karlsson A
    PLoS One; 2016; 11(1):e0147773. PubMed ID: 26816344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of the thioredoxin system by PX-12 (1-methylpropyl 2-imidazolyl disulfide) impedes HIV-1 infection in TZM-bl cells.
    Lundberg M; Mattsson Å; Reiser K; Holmgren A; Curbo S
    Sci Rep; 2019 Apr; 9(1):5656. PubMed ID: 30948772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein-disulfide isomerase-mediated reduction of two disulfide bonds of HIV envelope glycoprotein 120 occurs post-CXCR4 binding and is required for fusion.
    Barbouche R; Miquelis R; Jones IM; Fenouillet E
    J Biol Chem; 2003 Jan; 278(5):3131-6. PubMed ID: 12218052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of interleukin-4 signaling by extracellular reduction of intramolecular disulfides.
    Curbo S; Gaudin R; Carlsten M; Malmberg KJ; Troye-Blomberg M; Ahlborg N; Karlsson A; Johansson M; Lundberg M
    Biochem Biophys Res Commun; 2009 Dec; 390(4):1272-7. PubMed ID: 19878651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitors of protein-disulfide isomerase prevent cleavage of disulfide bonds in receptor-bound glycoprotein 120 and prevent HIV-1 entry.
    Gallina A; Hanley TM; Mandel R; Trahey M; Broder CC; Viglianti GA; Ryser HJ
    J Biol Chem; 2002 Dec; 277(52):50579-88. PubMed ID: 12218051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Snapshot of the interaction between HIV envelope glycoprotein 120 and protein disulfide isomerase.
    Wang Z; Zhou Z; Guo ZY; Chi CW
    Acta Biochim Biophys Sin (Shanghai); 2010 May; 42(5):358-62. PubMed ID: 20458450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of a small molecule PDI inhibitor that inhibits reduction of HIV-1 envelope glycoprotein gp120.
    Khan MM; Simizu S; Lai NS; Kawatani M; Shimizu T; Osada H
    ACS Chem Biol; 2011 Mar; 6(3):245-51. PubMed ID: 21121641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thiol/disulfide exchange is a prerequisite for CXCR4-tropic HIV-1 envelope-mediated T-cell fusion during viral entry.
    Markovic I; Stantchev TS; Fields KH; Tiffany LJ; Tomiç M; Weiss CD; Broder CC; Strebel K; Clouse KA
    Blood; 2004 Mar; 103(5):1586-94. PubMed ID: 14592831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of protein disulfide isomerase and other thiol-reactive proteins in HIV-1 envelope protein-mediated fusion.
    Ou W; Silver J
    Virology; 2006 Jul; 350(2):406-17. PubMed ID: 16507315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. S-glutathiolated hepatocyte proteins and insulin disulfides as substrates for reduction by glutaredoxin, thioredoxin, protein disulfide isomerase, and glutathione.
    Jung CH; Thomas JA
    Arch Biochem Biophys; 1996 Nov; 335(1):61-72. PubMed ID: 8914835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disulfide bond that constrains the HIV-1 gp120 V3 domain is cleaved by thioredoxin.
    Azimi I; Matthias LJ; Center RJ; Wong JW; Hogg PJ
    J Biol Chem; 2010 Dec; 285(51):40072-80. PubMed ID: 20943653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NHERF1 regulates gp120-induced internalization and signaling by CCR5, and HIV-1 production.
    Kuang YQ; Pang W; Zheng YT; Dupré DJ
    Eur J Immunol; 2012 Feb; 42(2):299-310. PubMed ID: 22028271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional analysis of the disulfide-bonded loop/chain reversal region of human immunodeficiency virus type 1 gp41 reveals a critical role in gp120-gp41 association.
    Maerz AL; Drummer HE; Wilson KA; Poumbourios P
    J Virol; 2001 Jul; 75(14):6635-44. PubMed ID: 11413331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disulfide reduction in CD4 domain 1 or 2 is essential for interaction with HIV glycoprotein 120 (gp120), which impairs thioredoxin-driven CD4 dimerization.
    Cerutti N; Killick M; Jugnarain V; Papathanasopoulos M; Capovilla A
    J Biol Chem; 2014 Apr; 289(15):10455-10465. PubMed ID: 24550395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Redox control on the cell surface: implications for HIV-1 entry.
    Matthias LJ; Hogg PJ
    Antioxid Redox Signal; 2003 Feb; 5(1):133-8. PubMed ID: 12626125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The catalytic activity of protein disulfide isomerase is involved in human immunodeficiency virus envelope-mediated membrane fusion after CD4 cell binding.
    Fenouillet E; Barbouche R; Courageot J; Miquelis R
    J Infect Dis; 2001 Mar; 183(5):744-52. PubMed ID: 11181151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell-type specific requirements for thiol/disulfide exchange during HIV-1 entry and infection.
    Stantchev TS; Paciga M; Lankford CR; Schwartzkopff F; Broder CC; Clouse KA
    Retrovirology; 2012 Dec; 9():97. PubMed ID: 23206338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.